In line with the improvement of cardiac functional parameters, the infarct size in MI mice treated with c-kit+ cell-seeded hHVS was also significantly reduced, when compared with that treated with the hHVS alone (Fig. 7b). This evidence concerns the gene KIT and myocardial infarction.